Publications and Presentations

Filter By:

Filanesib

12/10/2012

American Society of Hematology Annual Meeting

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma

J.J. Shah, MD, et al.

ARRY-614

12/09/2012

American Society of Hematology Annual Meeting

Role of p38 MAPK and Tie2 in the Pathogenesis of MDS and Their Inhibition by Dual Inhibitor ARRY-614

S. L. Winski, et al.

Filanesib

12/08/2012

American Society of Hematology Annual Meeting

Identification of Alpha 1-Acid Glycoprotein (AAG) as a Potential Patient Selection Biomarker for Improved Clinical Activity of the Novel KSP Inhibitor ARRY-520 in Relapsed and Refractory Multiple Myeloma (MM)

B.J. Tunquist, et al.

Selumetinib

11/28/2012

The Lancet Oncology

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

P. A. Janne, et al.

ARRY-380

10/17/2012

American Association of Pharmaceutical Scientists, Annual Meeting and Exposition

Amorphous Dispersion Development of ARRY-380, an ErbB2 Selective Inhibitor

C. Lindemann, et al.

ARRY-380

10/17/2012

American Association of Pharmaceutical Scientists, Annual Meeting and Exposition

Solid-State Characterization of Seven Isomorphic Solvates of ARRY-380

C. Lindemann, et al.

Ipatasertib

10/14/2012

International Society for the Study of Xenobiotics North American Regional Meeting

Preclinical ADME Evaluation of GDC-0068, a Novel, ATP-competitive Akt Inhibitor

B. M. Liederer, et al

Ipatasertib

09/28/2012

European Society for Medical Oncology Congress

Phase Ib Dose Escalation Study of the Akt Inhibitor GDC-0068 with Docetaxel or mFOLFOX6 in Patients with Advanced Solid Tumors

J.C. Bendell, et al.

Ipatasertib

08/30/2012

Journal of Medicinal Chemistry

Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors

J. F. Blake, et al.

TrkA

08/29/2012

International Association for the Study of Pain World Congress on Pain

Allosteric Small Molecule Inhibitors of the NGF/TrkA Pathway, A New Approach to Treating Inflammatory Pain

S. W. Andrews, Ph.D.